Proton Therapy for Early Stage Breast Cancer

Status Completed

Clinical Trial Summary

The purpose of this study is to determine if partial breast proton therapy is effective treatment for early stage breast cancer following lumpectomy.

Clinical Trial Description

Radiation therapy is considered standard treatment for most women with early stage breast cancer following lumpectomy. Post-lumpectomy radiotherapy is a proven treatment that reduces cancer recurrence in the breast and improves survival. When standard whole breast radiation techniques are utilized, portions of the chest wall, lung and heart may also receive significant doses of radiation which can lead to radiation induced complications. Radiation techniques that limit the treatment area to the portion of the breast where the cancer arose can minimize and even eliminate radiation dose to the chest wall, heart and lung. This is called partial breast radiotherapy. This study is designed to evaluate the use of proton beam radiotherapy to deliver partial breast radiotherapy in women with early stage breast cancer. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00614172
Study type	Interventional
Source	Loma Linda University
Contact
Status	Completed
Phase	N/A
Start date	February 2004
Completion date	May 12, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05528263` - Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)	N/A
Completed	`NCT00165243` - Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer	Phase 2
Recruiting	`NCT05559164` - Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted	Phase 2
Completed	`NCT03948568` - Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)	Phase 4
Recruiting	`NCT04553770` - Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer	Phase 2
Recruiting	`NCT06001762` - TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer	Phase 2
Active, not recruiting	`NCT03664687` - Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)	Phase 4
Recruiting	`NCT04603209` - Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
Completed	`NCT00233077` - Patient Centered Randomized Controlled Trial	N/A
Recruiting	`NCT02958033` - Shandong Cancer Hospital Affiliated to Shandong University	Phase 3
Recruiting	`NCT03797248` - Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast Cancer
Recruiting	`NCT03788083` - Intratumoral TriMix Injections in Early Breast Cancer Patients	Phase 1
Recruiting	`NCT05582499` - Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy	Phase 1/Phase 2
Recruiting	`NCT05871437` - Huaier Granule on Reducing the Level of Tumor Markers in Patients With Early-stage Breast Cancer	Phase 4
Recruiting	`NCT04003558` - Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)
Terminated	`NCT03894007` - Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer	Phase 2
Recruiting	`NCT02982148` - Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients	Phase 4
Active, not recruiting	`NCT03553797` - Accelerated Whole Breast Irradiation Hypofractionation Plus Boost VS Standard Whole Breast Irradiation Plus Boost	Phase 3
Recruiting	`NCT06215469` - Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)	N/A
Enrolling by invitation	`NCT06409221` - VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study